Oncogenic Mutations in RIT1 Ablate LZTR1-mediated Proteolysis

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2019-042
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Technique Pinpoints Oncogenic BRCA1 Mutations

Cancer Discovery
Oncology
2018English

Mapping the Unique and Shared Functions of Oncogenic KRAS and RIT1 With Proteome and Transcriptome Profiling

2020English

Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases

Frontiers in Immunology
AllergyImmunology
2018English

Oncogenic Β-Catenin Mutations Evade pH-regulated Degradation

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2019English

Oncogenic Mutations and Dysregulated Pathways in Obesity-Associated Hepatocellular Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2016English

Allosteric Activation of PI3Kα By Oncogenic Mutations

Oncotarget
Oncology
2013English

Comprehensive Analysis of Targetable Oncogenic Mutations in Chinese Cervical Cancers

Oncotarget
Oncology
2015English

Phosphatidylinositol 3-Kinase Mutations Identified in Human Cancer Are Oncogenic

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Regulation of Neurogenin Stability by Ubiquitin-Mediated Proteolysis

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy